
Spot the impact
One third of the population suffers from at least one skin condition.
Skin diseases impair patients’ quality of life more drastically than cancer and diabetes.
Biologicals and small-molecule inhibitors have created an unprecedented potential for precision medicine. Diagnostics is lagging behind.
Discover our solution
Groundbreaking translational research meets cutting-edge technology – Dermagnostix provides unique diagnostic tests for unmet clinical needs in dermatology on a fully automated portable laboratory.
With PsorX, Dermagnostix launches the first in-class molecular test for differential diagnosis of psoriasis and eczema.


Be one step ahead
Get diagnostic support for hard-to-tackle skin diseases using our simple and fast system:
Sample into LabDisk – LabDisk into Analyzer – Answer out.
Dermagnostix provides molecular diagnostic solution for dermatology.

economic

fast

easy

precise
Learn more about us
Brilliant minds from dermatology, molecular biology, microfluidics engineering and artificial intelligence have joined forces to help patients suffering from skin diseases and stigmatization get accurate diagnoses to improve their quality of life.

Natalie Garzorz-Stark, MD, PhD, MHBA
CEO, Dermatologist

Katharina Dormanns, PhD
Microfluidics Engineer

Prof. Kilian Eyerich, MD, PhD
Dermatologist

Prof. Stefanie Eyerich, PhD
Biologist

Prof. Kristian Reich, MD, PhD
Dermatologist

Prof. Christoffer Gebhardt, MD, PhD
Dermatologist

Prof. Fabian Theis, PhD, PhD
Mathematician, Physicist

Lucca Weber, M.Sc.
Life Science Engineer

PD Nils Paust, PhD
Microfluidics Engineer